Vijay Garg, joint managing director, IOL Chemicals and Pharmaceuticals said that the ibuprofen price increase is around 20-30 percent and the 20 percent price increase is in Indian market whereas international market prices has gone up by 30 percent.
“The profitability in ibuprofen has increased because of ibuprofen price increase in the market,” he added.
He further said that ibuprofen prices likely to sustain as there is short supply and rise in demand.
Talking about capacity, Garg said, “We were operating our plant at 72,000 tonne per annum last year, so now my capacity has increased up to 10,000 tonne.”
"We don't see higher supply until 2021 when BASF's plant comes on stream," he said.